Reduced number of cardiovascular events and increased cost-effectiveness by genotype-guided antiplatelet therapy in patients undergoing percutaneous coronary interventions in the Netherlands
Crossref DOI link: https://doi.org/10.1007/s12471-016-0873-z
Published Online: 2016-08-29
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deiman, B. A. L. M.
Tonino, P. A. L.
Kouhestani, K.
Schrover, C. E. M.
Scharnhorst, V.
Dekker, L. R. C.
Pijls, N. H. J.
License valid from 2016-08-29